Related Experiment Video
Updated: May 30, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.2K
MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer
Andrea Gaetano Allegra1, Luca Nicosia1, Michele Rigo1
1Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Verona, Negrar, Italy.
Technology in Cancer Research & Treatment
|January 27, 2025
Summary
MR-guided radiotherapy (MRgRT) offers enhanced precision for prostate cancer treatment. This review details the technology, clinical results, and future applications of MRgRT in managing prostate cancer.
Area of Science:
- Radiation Oncology
- Medical Physics
- Oncology
Background:
- MR-guided radiotherapy (MRgRT) integrates MRI with linear accelerators for advanced radiation delivery.
- This technology enables real-time imaging for precise tumor targeting and adaptive treatment planning.
- Prostate cancer is a primary focus for evaluating MRgRT's clinical utility.
Purpose of the Study:
- To review the current state of MR-guided radiotherapy for prostate cancer.
- To summarize technological advancements and clinical outcomes.
- To explore future directions for MRgRT in prostate cancer management.
Main Methods:
- Review of existing literature on MRgRT for prostate cancer.
- Description of the technology integrating MRI scanners with linear accelerators.
- Analysis of published clinical results and treatment adaptations.
Main Results:
- MRgRT demonstrates potential for increased precision and improved tolerability in radiation treatments.
- Daily online treatment plan adaptation is a key feature enabling personalized therapy.
- Ongoing investigations show promising results for MRgRT in prostate cancer care.
Conclusions:
- MR-guided radiotherapy represents a significant advancement in radiation oncology for prostate cancer.
- The technology facilitates highly accurate and adaptable treatment strategies.
- Future applications are expected to further refine prostate cancer management with MRgRT.

